Ron Finklestien
Billionaire’s Firm Wrong About AT&T – Seek These High-Yielding Stocks
Billionaire’s Firm Wrong About AT&T – Seek These High-Yielding Stocks
AT&T stock (NYSE:T) maintains its perch as a highly coveted investment on Seeking Alpha. This is mostly due to the allure of its seemingly ...
Rhythm Pharmaceuticals Screening for Phase 3 Anti-Obesity Study
Rhythm Pharmaceuticals: Shaping the Future of Anti-Obesity Drug Development
Nastassia Samal Rhythm Pharmaceuticals (NASDAQ:RYTM) has accomplished a significant milestone in its journey towards combating obesity. The company has wrapped up the screening for ...
Allegro MicroSystems, Inc.: Navigating the Wall Street Recommendation Maze
Before you decide to bet the farm on Allegro MicroSystems, Inc. (ALGM), a word to the wise about those Wall Street analysts: They may ...
LG Display Unveils 480Hz QHD Gaming OLED Screens at CES 2024
LG Display Unveils 480Hz QHD Gaming OLED Screens at CES 2024
LG Display is set to introduce an array of its latest Gaming Organic Light Emitting Diode (OLED) displays at the Consumer Electronics Show (CES) ...
Novo Nordisk Collaborates for Cardiometabolic Diseases
Famed Obesity Drug Maker Novo Nordisk Inks Collaborations For Cardiometabolic Diseases
Introduction Novo Nordisk A/S (NVO), Omega Therapeutics Inc (OMGA), and Cellarity Inc have joined forces in groundbreaking research collaborations. These partnerships have the potential ...
Income Potential: Analyzing Two Dividend Opportunities
Since time immemorial, the pursuit of a perpetual motion machine has captivated the human imagination. An apparatus that could run indefinitely, once set in ...
EV Startup Fisker Embraces Dealership Model To Boost Sales – What's On The Cards?
Fisker’s Bold Move: Dealership Model to Skyrocket Sales Fisker’s Dealer Partnership Model Fisker Inc FSR revealed its plans to develop a Dealer Partnership model in ...
The Rise of MAIA Biotechnology’s Potential in Oncology
MAIA Biotechnology’s Breakthrough in Oncology MAIA Biotechnology (NYSE:MAIA) entered the biotech IPO scene in 2022 with a modest $20 million market cap. The company’s ...
European Airlines Face Turbulent Times
European Airlines Face Turbulent Times
Boarding1Now/iStock Editorial via Getty Images As the European airline industry braces for another challenging year, there are indications of potential bright spots in the ...
Analysis of Top-Rated Stocks for January 4th
Analysis of Top-Rated Stocks for January 4th
Behold the emerging stars! Five wonder stocks have ascended to the zenith, etching their names on the prestigious Zacks Rank #1 (Strong Buy) list. ...
